Back to Results
First PageMeta Content
Clinical medicine / Breakthrough therapy / Medicine / Antineoplastic drugs / Pharmacology / Monoclonal antibodies / Bristol-Myers Squibb / Nivolumab / Melanoma / Programmed cell death protein 1 / Pembrolizumab / Raltegravir


12 JulyGeraldine MacGibbon Senior Therapeutic Group Manager PHARMAC PO Box
Add to Reading List

Document Date: 2016-07-11 21:31:12

Open Document

File Size: 204,40 KB

Share Result on Facebook
UPDATE